oxonic acid has been researched along with Intestinal Neoplasms in 8 studies
Oxonic Acid: Antagonist of urate oxidase.
Intestinal Neoplasms: Tumors or cancer of the INTESTINES.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paclitaxel was given intravenously on days 1, 8, and 15, starting with a dose of 40 mg m-2 day-1." | 2.72 | Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer. ( Aihara, R; Asao, T; Haga, N; Kamiyama, Y; Kuwano, H; Mochiki, E; Nakabayashi, T; Nakamura, J; Ohno, T; Ohsawa, H; Ojima, H; Takeuchi, K, 2006) |
| "As there is no standard treatment for advanced gastric cancer refractory to first-line chemotherapy, the feasibility of S-1 plus weekly docetaxel combined with concurrent radiotherapy was evaluated." | 1.35 | Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy. ( Fujitani, K; Hirao, M; Kurokawa, Y; Tsujinaka, T; Yamasaki, H; Yoshida, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takayoshi, K | 1 |
| Kusaba, H | 1 |
| Uenomachi, M | 1 |
| Mitsugi, K | 1 |
| Makiyama, C | 1 |
| Makiyama, A | 1 |
| Uchino, K | 1 |
| Shirakawa, T | 1 |
| Shibata, Y | 1 |
| Shinohara, Y | 1 |
| Inadomi, K | 1 |
| Tsuchihashi, K | 1 |
| Arita, S | 1 |
| Ariyama, H | 1 |
| Esaki, T | 1 |
| Akashi, K | 1 |
| Baba, E | 1 |
| Fujitani, K | 1 |
| Tsujinaka, T | 1 |
| Yamasaki, H | 1 |
| Hirao, M | 1 |
| Yoshida, K | 1 |
| Kurokawa, Y | 1 |
| Aoki, Y | 1 |
| Kameda, A | 1 |
| Miyahara, E | 1 |
| Funakoshi, M | 1 |
| Okubo, K | 1 |
| Yoshioka, S | 1 |
| Asukai, K | 1 |
| Hata, T | 1 |
| Nakanishi, M | 1 |
| Maekawa, T | 1 |
| Hama, N | 1 |
| Kashiwazaki, M | 1 |
| Taniguchi, M | 1 |
| Tsujie, M | 1 |
| Konishi, M | 1 |
| Yano, K | 1 |
| Fujimoto, T | 1 |
| Kotake, M | 1 |
| Murakami, N | 1 |
| Bandou, H | 1 |
| Morita, K | 1 |
| Koizumi, H | 1 |
| Yoshino, H | 1 |
| Tawaraya, K | 1 |
| Ishiguro, K | 1 |
| Kinoshita, S | 1 |
| Yamada, T | 1 |
| Ishizone, S | 1 |
| Maruta, F | 1 |
| Saito, H | 1 |
| Koide, N | 1 |
| Sugiyama, A | 1 |
| Nakayama, J | 1 |
| Miyagawa, S | 1 |
| Mochiki, E | 1 |
| Ohno, T | 1 |
| Kamiyama, Y | 1 |
| Aihara, R | 1 |
| Haga, N | 1 |
| Ojima, H | 1 |
| Nakamura, J | 1 |
| Ohsawa, H | 1 |
| Nakabayashi, T | 1 |
| Takeuchi, K | 1 |
| Asao, T | 1 |
| Kuwano, H | 1 |
| Takayama, T | 1 |
| Sato, Y | 1 |
| Sagawa, T | 1 |
| Okamoto, T | 1 |
| Nagashima, H | 1 |
| Takahashi, Y | 1 |
| Ohnuma, H | 1 |
| Kuroiwa, G | 1 |
| Miyanishi, K | 1 |
| Takimoto, R | 1 |
| Matsunaga, T | 1 |
| Kato, J | 1 |
| Yamaguchi, K | 1 |
| Hirata, K | 1 |
| Niitsu, Y | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer[NCT01291407] | Phase 1 | 27 participants (Actual) | Interventional | 2010-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for oxonic acid and Intestinal Neoplasms
| Article | Year |
|---|---|
Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Disease Progression; Drug Combinations; | 2006 |
Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Drug Combinations; Femal | 2007 |
6 other studies available for oxonic acid and Intestinal Neoplasms
| Article | Year |
|---|---|
Suggestion of added value by bevacizumab to chemotherapy in patients with unresectable or recurrent small bowel cancer.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Beva | 2017 |
Feasibility study of S-1 plus weekly docetaxel combined with concurrent radiotherapy in advanced gastric cancer refractory to first-line chemotherapy.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Doc | 2009 |
[A patient with small intestinal cancer and extensive lymph node metastasis who responded to S-1].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Drug Combinations; Endosc | 2010 |
[A case report of primary adenocarcinoma of small intestine].
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; | 2010 |
[A case of primary small intestinal cancer accompanied by virchow lymph node metastasis undergoing TS-1 treatment].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Combinatio | 2005 |
Efficacy of S-1 for patients with peritoneal metastasis of gastric cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Biomarkers, Tumor; Dihydrouracil Dehydrogenase (NADP); | 2006 |